AADI BIOSCIENCE

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Oct 2025 filing date already counts against anyone who files later.

Record

Serial number

99464336

Mark type

Design + words

Filed

27 Oct 2025

Published for opposition

07 Apr 2026

Attorney of record

Aaron D. Hendelman

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Vaccine preparations; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of vascular malformations; Pharmaceutical preparations for the prevention and treatment of vascular system related diseases and disorders; Pharmaceutical preparations for use in plastic surgery; Pharmaceutical preparations for the treatment of tissue overgrowth related diseases and disorders; Pharmaceutical preparations for the treatment of vascular anomalies

Owner

• Aadi Bioscience, Inc., Morristown, NJ, US

Prosecution history

• 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 12 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 12 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
• 12 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 12 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
• 12 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
• 12 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
• 12 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 12 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
• 12 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
• 11 Mar 2026 — ASSIGNED TO EXAMINER
• 07 Mar 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
• 08 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 27 Oct 2025 — APPLICATION FILING RECEIPT MAILED
• 27 Oct 2025 — NEW APPLICATION ENTERED